Cenestin and Xopenex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cenestin (estrogens, conjugated synthetic a) and Xopenex (levalbuterol hydrochloride). Common drug interactions include dyspnoea among females.

The phase IV clinical study analyzes what interactions people have when they take Cenestin and Xopenex. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Cenestin?

Cenestin has active ingredients of estrogens, conjugated synthetic a. It is often used in hormone replacement therapy. eHealthMe is studying from 1,301 Cenestin users. Check the latest studies of Cenestin.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.



On Aug, 08, 2026

16 people who take Cenestin and Xopenex together, and have interactions are studied.

Cenestin and Xopenex drug interactions.

What are the common drug interactions of Cenestin and Xopenex, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Headache (pain in head)
  3. Oropharyngeal discomfort (pain or irritation of oropharynx)
  4. Seasonal allergy (allergic condition due to certain season)
  5. Vision blurred
  6. Myalgia (muscle pain)
  7. Asthenia (weakness)
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Neck pain

male:

n/a

What are the common drug interactions of Cenestin and Xopenex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Myalgia (muscle pain)
  3. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  4. Nasal discomfort
  5. Rhinorrhoea (watery mucus discharge from the nose)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 9 people, 56.25%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 37.50%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Cenestin and Xopenex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cenestin and Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cenestin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cenestin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xopenex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on estrogens, conjugated synthetic a and levalbuterol hydrochloride (the active ingredients of Cenestin and Xopenex, respectively), and Cenestin and Xopenex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: